Demetris AJ et al. |
Pathologic observations in human allograft recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689891
|
Kumar MS et al. |
ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis. |
1998 |
Transplant. Proc. |
pmid:9636549
|
Asselin I et al. |
Polymerase chain reaction-based assay to assess the success of myoblast transplantation in mdx mice. |
1994 |
Transplant. Proc. |
pmid:7527970
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Diez Ojea B et al. |
Three-month experience with tacrolimus once-daily regimen in stable renal allografts. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715908
|
Azhderian EM et al. |
Nucleus associated FK 506 binding proteins with potential relevance to FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7679834
|
Corry RJ et al. |
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. |
1998 |
Transplant. Proc. |
pmid:9532157
|
Dheir H et al. |
Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance. |
2011 |
Transplant. Proc. |
pmid:21486617
|
Waller JR et al. |
Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808582
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Cimsit B et al. |
Successful treatment of fibrosing cholestatic hepatitis after liver transplantation. |
2011 |
Transplant. Proc. |
pmid:21486625
|
Zhao Y et al. |
Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808586
|
Kawauchi M et al. |
Plasma level of FK 506 in newborn goats and infant baboons. |
1991 |
Transplant. Proc. |
pmid:1721267
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Morozumi K et al. |
A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar? |
1996 |
Transplant. Proc. |
pmid:8623232
|
Takada S et al. |
HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats. |
1996 |
Transplant. Proc. |
pmid:8623236
|
Shimada H et al. |
Existence of serum p53 antibodies in cyclosporine A-treated transplant patients: possible detection of p53 protein over-expression. |
2000 |
Transplant. Proc. |
pmid:11119931
|
Vela CG et al. |
Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients. |
2000 |
Transplant. Proc. |
pmid:10715453
|
Kim HC and Park SB |
Mycophenolate mofetil-induced ischemic colitis. |
2000 |
Transplant. Proc. |
pmid:11119990
|
Land W et al. |
Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients. |
2001 |
Transplant. Proc. |
pmid:11406265
|
DÃaz-Molina B et al. |
Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation. |
2012 |
Transplant. Proc. |
pmid:23146479
|
Maggard M et al. |
Incidence of acute rejection in African-American liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636607
|
Watarai Y et al. |
Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production. |
2004 |
Transplant. Proc. |
pmid:15518773
|
Furlan V et al. |
Interaction between tacrolimus and itraconazole in a heart-lung transplant recipient. |
1998 |
Transplant. Proc. |
pmid:9474996
|
Birk PE et al. |
Preliminary experience with FK 506 in pediatric renal transplant recipients: a single-center report. |
1996 |
Transplant. Proc. |
pmid:8623493
|
Nelson PA et al. |
Effect of immunosuppressive drugs on cytokine gene transcription studied by message amplification phenotyping (MAPPing) polymerase chain reaction. |
1991 |
Transplant. Proc. |
pmid:1721299
|
Ishibashi M et al. |
Elimination of the adverse effects of tacrolimus-based induction therapy by a 5-day exposure of optimal steady-state blood concentration in renal transplant patients in the early postoperative period. |
1999 |
Transplant. Proc. |
pmid:10578281
|
Telkes G et al. |
Kidney transplantation in hereditary coproporphyria using tacrolimus and mycophenolate mofetil: a case report. |
2013 |
Transplant. Proc. |
pmid:24315002
|
González-Pinto IM et al. |
Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919441
|
Nakamura Y et al. |
Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy. |
2005 |
Transplant. Proc. |
pmid:15919445
|
Jain A et al. |
FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. |
1994 |
Transplant. Proc. |
pmid:7518149
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Furukawa H and Todo S |
Evolution of immunosuppression in liver transplantation: contribution of cyclosporine. |
2004 |
Transplant. Proc. |
pmid:15041353
|
Hatazawa C et al. |
Effect of FK 506 on bowel transplantation in rats. |
1992 |
Transplant. Proc. |
pmid:1376517
|
Zeevi A et al. |
Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients. |
1995 |
Transplant. Proc. |
pmid:7533388
|
Watanabe K et al. |
Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. |
1995 |
Transplant. Proc. |
pmid:7533389
|
Kawauchi M et al. |
Flow cytometric analysis of lymphocyte populations in FK 506-treated newborn goats. |
1991 |
Transplant. Proc. |
pmid:1721331
|
Ishikawa T et al. |
Intestinal function and morphology after ex vivo irradiated small bowel transplantation. |
2002 |
Transplant. Proc. |
pmid:12034274
|
Charco R et al. |
Changes in renal function in long-term survivors of liver transplantation: a comparison between cyclosporine microemulsion and tacrolimus therapy. |
2002 |
Transplant. Proc. |
pmid:12176478
|
Dierickx D et al. |
Thrombotic microangiopathy following intestinal transplantation: a single center experience. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172285
|
Yokoyama I et al. |
Immunosuppressant effect on Fas antigen expression and p53 of an experimental tumor. |
1998 |
Transplant. Proc. |
pmid:9865346
|
Prasad GV et al. |
Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. |
2005 |
Transplant. Proc. |
pmid:15919496
|
Kobayashi M et al. |
Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch. |
1992 |
Transplant. Proc. |
pmid:1281570
|
|
Japanese study of FK 506 on kidney transplantation: results of an early phase II study. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721363
|
Miller J et al. |
FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123008
|
van Hoek B et al. |
Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome. |
1991 |
Transplant. Proc. |
pmid:1703343
|
Jensen CW et al. |
Pediatric renal transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721364
|
McCauley J et al. |
The question of FK 506 nephrotoxicity after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1703344
|
Toyama Y et al. |
Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506. |
1996 |
Transplant. Proc. |
pmid:8907924
|
Malaise J et al. |
Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182828
|
Malaise J et al. |
Corticosteroid withdrawal in simultaneous pancreas-kidney transplantation: a 3-year report. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182832
|
Crespo-Leiro MG |
Tacrolimus in heart transplantation. |
2003 |
Transplant. Proc. |
pmid:12962869
|
Espà A et al. |
Influence of hepatic ischemia-reperfusion injury on tacrolimus acute renal toxicity in pigs. |
2002 |
Transplant. Proc. |
pmid:12493373
|
Aumente Rubio MD et al. |
Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring. |
2003 |
Transplant. Proc. |
pmid:12962871
|
Soylu H et al. |
Survival of renal transplant patients: data from a tertiary care center in Turkey. |
2015 |
Transplant. Proc. |
pmid:25769571
|
Dietl KH |
Oral dosing of tacrolimus and cyclosporine microemulsion--results from a large multicenter study in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176524
|
Karakulska-Prystupiuk E et al. |
Pericarditis in Patients With Chronic Graft-vs-Host Disease. |
2018 |
Transplant. Proc. |
pmid:30177139
|
Gurkan A et al. |
Comparison of tacrolimus and neoral-based immunosuppressive regimens in renal transplantation patients: singles-center experience. |
2002 |
Transplant. Proc. |
pmid:12176525
|
Humar A et al. |
Surgical complications requiring early relaparotomy after pancreas transplantation: comparison of the cyclosporine and FK 506 eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083256
|
Shapiro R et al. |
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. |
1997 |
Transplant. Proc. |
pmid:9290809
|
Tsuchiya T et al. |
Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stable kidney transplant recipients. |
2012 |
Transplant. Proc. |
pmid:22310593
|
Kumano K et al. |
Role of the transforming growth factor and monocyte chemoattractant protein in FK506-induced nephropathy in the rat. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123293
|
Gudas VM et al. |
Comparison of the immunosuppressive and toxic effects of FK506 and cyclosporine in xenograft recipients. |
1989 |
Transplant. Proc. |
pmid:2468211
|
Carroll PB et al. |
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. |
1991 |
Transplant. Proc. |
pmid:1721396
|
Grochowicz PM et al. |
Synergistic interaction between castanospermine and tacrolimus in a rat heart allograft model. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123296
|
Wilczek HE et al. |
Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506). |
1996 |
Transplant. Proc. |
pmid:8962232
|
Yussim A et al. |
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. |
1996 |
Transplant. Proc. |
pmid:8962233
|
Wierzbicka A et al. |
Lipid, carbohydrate metabolism, and antioxidant status in children after liver transplantation. |
2007 |
Transplant. Proc. |
pmid:17580179
|
Nakache R et al. |
Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization. |
2001 |
Transplant. Proc. |
pmid:11377533
|
Baran DA et al. |
A novel tacrolimus dosing strategy in cardiac transplantation: drug levels, renal function, and biopsy results. |
2002 |
Transplant. Proc. |
pmid:12176595
|
Ettenger R |
The practical problems of prednisone in pediatric renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267159
|
Sánchez Pérez B et al. |
Adverse effects on the lipid profile of immunosuppressive regimens: tacrolimus versus cyclosporin measured using C2 levels. |
2009 |
Transplant. Proc. |
pmid:19376418
|
Reggiani P et al. |
Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9723308
|
Testillano M et al. |
Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. |
2009 |
Transplant. Proc. |
pmid:19376421
|
Takeda Y et al. |
Effect of FK 506 on the survival of rat small bowel allografts. |
1991 |
Transplant. Proc. |
pmid:1721426
|
Kokado Y et al. |
Hypertension in renal transplant recipients and its effect on long-term renal allograft survival. |
1996 |
Transplant. Proc. |
pmid:8658802
|
Fukuzawa M et al. |
Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation. |
1991 |
Transplant. Proc. |
pmid:1721427
|
Park KM et al. |
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. |
1996 |
Transplant. Proc. |
pmid:8658863
|
Kishikawa H et al. |
Low-dose steroid maintenance for renal transplant recipients. |
2010 |
Transplant. Proc. |
pmid:21168618
|
Tamura K et al. |
A highly sensitive method to assay FK-506 levels in plasma. |
1987 |
Transplant. Proc. |
pmid:2445069
|
Tinti F et al. |
Improvement of graft function after conversion to once daily tacrolimus of stable kidney transplant patients. |
2010 |
Transplant. Proc. |
pmid:21168623
|
Venkataramanan R et al. |
Biopharmaceutical aspects of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445070
|
Ji SM et al. |
Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection. |
2006 |
Transplant. Proc. |
pmid:17175303
|
Shaffer D et al. |
Calcineurin inhibitor avoidance versus steroid avoidance following kidney transplantation: Postoperative complications. |
2006 |
Transplant. Proc. |
pmid:17175304
|
López-Vilella R et al. |
Incidence of development of obesity after heart transplantation according to the calcineurin inhibitor. |
|
Transplant. Proc. |
pmid:25645789
|
Mueller AR et al. |
Influence of immunosuppression on patient survival after liver transplantation for hepatitis C. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267321
|
Cofan F et al. |
Fatty acid composition in low-density lipoproteins from renal transplant recipients. |
1999 |
Transplant. Proc. |
pmid:10500603
|
Kattner A et al. |
Conversion from CyA to CyA-NOF in a cholestatic liver grafted patient with CyA malabsorption. |
1994 |
Transplant. Proc. |
pmid:7524225
|
Abou-Jaoude MM et al. |
Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients. |
2005 |
Transplant. Proc. |
pmid:16213293
|
Carroll PB et al. |
The use of FK 506 in new-onset type I diabetes in man. |
1991 |
Transplant. Proc. |
pmid:1721458
|
Wakabayashi H et al. |
Effect of FK 506 and cyclosporine A on hepatic energy status in the rat after warm ischemia, as monitored by 31P nuclear magnetic resonance spectroscopy in vivo. |
1992 |
Transplant. Proc. |
pmid:1384205
|
Mita A et al. |
Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation. |
2014 |
Transplant. Proc. |
pmid:24767351
|
Braun F et al. |
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636496
|
Tanabe K et al. |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636497
|
Mehra MR et al. |
Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. |
2004 |
Transplant. Proc. |
pmid:15686716
|
Hildebrandt A et al. |
FK 506: short- and long-term treatment after cardiac transplantation in nonhuman primates. |
1991 |
Transplant. Proc. |
pmid:1703694
|
Dallos G et al. |
Results and complications after living related kidney transplantation in Hungary: 30 years' experience. |
2010 Jul-Aug |
Transplant. Proc. |
pmid:20692470
|
Williams ST et al. |
Preliminary analysis of a randomized trial comparing microemulsion cyclosporine and tacrolimus for recipients of renal transplants from non-heart-beating donors. |
2000 |
Transplant. Proc. |
pmid:10701022
|
Boggi U et al. |
Single-center, open, prospective, randomized pilot study comparing cyclosporine versus tacrolimus in simultaneous pancreas-kidney transplantation. |
2004 |
Transplant. Proc. |
pmid:15194369
|